Search Results

June 2022 "Published on juin 22, 2022 On June 22, 2022, Michel Bouvier, Chief Executive Officer of IRIC

Michelle Halls This episode goes beyond the bench. Dr. Michelle Halls dissects how spatial GPCR signaling shifts discovery—and how leadership, mentorship, and

I didn’t expect to love it, says Michelle Halls. The Accidental Beginning Michelle hadn’t mapped out a scientific empire. The Moment It Clicked Once the initial spark was lit, Michelle’s curiosity snowballed. Curiosity wasn’t just something Michelle felt — it started steering every decision she made. . 🎧 Listen to the full conversation with Michelle Halls on  The Dr.

Watch Episode 176 The first time Michelle ran a cyclic AMP assay, she did it with a single-channel pipette Michelle describes spending hours in the lab measuring cyclic AMP levels — without multi-channel pipettes Michelle notes that the real shift wasn’t just speed. It was confidence. The Mindset Shift: From Technique to Strategy Michelle reflects on how early-career researchers once Michelle’s path wasn’t linear.

It was about what we could build together, recalls Michelle Halls. Michelle was part of a cohort that joined as postgrads in shared facilities, pooling reagents, ideas, What Happens When Labs Stop Competing Michelle credits this environment for catalyzing the GPCR signaling Michelle notes that the absence of individual ownership over physical space or specialized equipment Michelle’s story shows what happens when an ecosystem is built deliberately, not accidentally. 

Michel Bouvier, Dr. Luisa Salter-Cid, Dr. Omar Nadeem and Dr.

Franziska Heydenreich, Sudarshan Rajagopal, Graham Ladds, Cesare Orlandi, Simone Prömel and Michel Bouvier

Badr Sokrat, Michel Bouvier, et al. for their study on the Role of the V2R-βarrestin-Gβγ complex in promoting

Franziska Heydenreich, Sudarshan Rajagopal, Graham Ladds, Cesare Orlandi, Simone Prömel and Michel Bouvier

Michel Bouvier, J Silvio Gutkind, and team found that Gαs is essential for GRK selectivity and gene regulation

Franziska Heydenreich, Sudarshan Rajagopal, Graham Ladds, Cesare Orlandi and Michel Bouvier.

Cheloha for their work on Highly biased agonism for GPCR ligands via nanobody tethering Elk Kossatz, Michel

Michel Bouvier received the title of Doctor Honoris Causa from the Université de Montpellier Domain Therapeutics

Franziska Heydenreich, Sudarshan Rajagopal, Graham Ladds, and Michel Bouvier.

Shane Wright, Michel Bouvier, et al., for their work on Conformation- and activation-based BRET sensors

Franziska Heydenreich, Sudarshan Rajagopal, Graham Ladds, and Michel Bouvier We will also have a poster

Franziska M Heydenreich, Michel Bouvier, Brian Kobilka, M Madan Babu, and their team's work on Molecular

Franziska Heydenreich, Sudarshan Rajagopal, Graham Ladds, Cesare Orlandi, Simone Prömel and Michel Bouvier

Franziska Heydenreich, Sudarshan Rajagopal, Graham Ladds, and Michel Bouvier.

and ligand bias of G protein-coupled receptors Antonios Drakopoulos, Peter Gmeiner, Davide Calebiro, Michael

et al. for their work on Conformational dynamics underlying atypical chemokine receptor 3 activation Michael

Congratulations to Domain Therapeutics for appointing Michael Gottlieb as Chairman and Dr.

.; Michel, B. Y.; Burger, A.